249 related articles for article (PubMed ID: 35597509)
1. In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B.
Escribano P; Gómez A; Reigadas E; Muñoz P; Guinea J;
Clin Microbiol Infect; 2022 Sep; 28(9):1291.e7-1291.e10. PubMed ID: 35597509
[TBL] [Abstract][Full Text] [Related]
2. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain.
Escribano P; Rodríguez-Sánchez B; Díaz-García J; Martín-Gómez MT; Ibáñez-Martínez E; Rodríguez-Mayo M; Peláez T; García-Gómez de la Pedrosa E; Tejero-García R; Marimón JM; Reigadas E; Rezusta A; Labayru-Echeverría C; Pérez-Ayala A; Ayats J; Cobo F; Pazos C; López-Soria L; Alastruey-Izquierdo A; Muñoz P; Guinea J;
Clin Microbiol Infect; 2021 Aug; 27(8):1170.e1-1170.e7. PubMed ID: 33010446
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
[TBL] [Abstract][Full Text] [Related]
4. Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato.
Serrano-Lobo J; Gómez A; Reigadas E; Muñoz P; Escribano P; Guinea J;
Mycoses; 2023 Mar; 66(3):196-201. PubMed ID: 36305878
[TBL] [Abstract][Full Text] [Related]
5. Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.
Monteiro C; Pinheiro D; Maia M; Faria MA; Lameiras C; Pinto E
J Appl Microbiol; 2019 Apr; 126(4):1140-1148. PubMed ID: 30735287
[TBL] [Abstract][Full Text] [Related]
6. Azole-Resistant Aspergillus fumigatus Clinical Isolate Screening in Azole-Containing Agar Plates (EUCAST E.Def 10.1): Low Impact of Plastic Trays Used and Poor Performance in Cryptic Species.
Serrano-Lobo J; Gómez A; Rodríguez-Sánchez B; Muñoz P; Escribano P; Guinea J;
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0048221. PubMed ID: 34252311
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Arendrup MC; Jensen RH; Cuenca-Estrella M
Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973
[TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal susceptibility profile and genotypic characterization of clinical Aspergillus isolates in Eastern China on behalf of Eastern China Invasive Fungi Infection Group.
Lin H; Guo J; Li Y; Xiao C; Hu L; Chen H; Lu X; Wu W
Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37580143
[TBL] [Abstract][Full Text] [Related]
9. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
[TBL] [Abstract][Full Text] [Related]
10. First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.
Astvad KM; Jensen RH; Hassan TM; Mathiasen EG; Thomsen GM; Pedersen UG; Christensen M; Hilberg O; Arendrup MC
Antimicrob Agents Chemother; 2014 Sep; 58(9):5096-101. PubMed ID: 24936595
[TBL] [Abstract][Full Text] [Related]
11. Azole and Amphotericin B MIC Values against
Serrano-Lobo J; Gómez A; Sánchez-Yebra W; Fajardo M; Lorenzo B; Sánchez-Reus F; Vidal I; Fernández-Torres M; Sánchez-Romero I; Ruiz de Alegría-Puig C; Del Pozo JL; Muñoz P; Escribano P; Guinea J
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33020164
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
Kirchhoff L; Dittmer S; Furnica DT; Buer J; Steinmann E; Rath PM; Steinmann J
J Antimicrob Chemother; 2022 May; 77(6):1645-1654. PubMed ID: 35289361
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
[TBL] [Abstract][Full Text] [Related]
14.
Talbot JJ; Frisvad JC; Meis JF; Hagen F; Verweij PE; Hibbs DE; Lai F; Groundwater PW; Samson RA; Kidd SE; Barrs VR; Houbraken J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451501
[TBL] [Abstract][Full Text] [Related]
15. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
[TBL] [Abstract][Full Text] [Related]
17. The emergence of azole resistance in Aspergillus fumigatus complex in New Zealand.
McKinney WP; Vesty A; Sood J; Bhally H; Morris AJ
N Z Med J; 2021 Jun; 134(1536):41-51. PubMed ID: 34140712
[TBL] [Abstract][Full Text] [Related]
18. Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes.
Jensen RH; Hagen F; Astvad KM; Tyron A; Meis JF; Arendrup MC
Clin Microbiol Infect; 2016 Jun; 22(6):570.e1-9. PubMed ID: 27091095
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies.
Rivero-Menendez O; Cuenca-Estrella M; Alastruey-Izquierdo A
J Antimicrob Chemother; 2019 Jun; 74(6):1586-1590. PubMed ID: 30891600
[TBL] [Abstract][Full Text] [Related]
20. Spectrophotometric azole and amphotericin B MIC readings against Aspergillus fumigatus sensu lato using the EUCAST 9.3.2 methodology. Are ≥90 and ≥95% fungal growth inhibition endpoints equally suitable?
Serrano-Lobo J; Gómez A; Muñoz P; Escribano P; Guinea J
Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34748019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
